GlassScriptPhysician profile
Sandeep Chopra
NPI 1952399024
$14,897.35
in general payments reported to CMS, 2019-2025
34 companies · $2,718 in 2025
The $2,718 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,713 · 2020: $1,150 · 2021: $2,590 · 2022: $2,705 · 2023: $2,276 · 2024: $1,745 · 2025: $2,718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,148 · Travel and Lodging: $590.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,148.29 |
| Travel and Lodging | $590.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,760.02 | 2019-2024 | Xarelto |
| Pfizer INC. | $1,645.15 | 2019-2025 | |
| Amgen INC. | $1,428.36 | 2019-2025 | Repatha, Repatha |
| Novo Nordisk INC | $1,029.66 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boston Scientific Corporation | $1,024.52 | 2025 | Watchman, Watchman Flx |
| Bayer Healthcare Pharmaceuticals INC. | $919.27 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $776.48 | 2019-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $698.55 | 2019-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $663.64 | 2019-2023 | |
| Amarin Pharma, INC. | $595.85 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $576.88 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $564.28 | 2021-2024 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $544.76 | 2020-2024 | Jardiance, Synjardy, Tradjenta |
| Merck Sharp & Dohme LLC | $475.44 | 2021-2025 | Verquvo, Capvaxive, Vaqta |
| Medtronic, INC. | $440.22 | 2021-2023 | Selectsecure |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $407.07 | 2019-2025 | Mitraclip, Aveir, Triclip |
| Esperion Therapeutics, INC. | $354.09 | 2020-2022 | |
| Lilly USA, LLC | $189.44 | 2020-2025 | Jardiance, Zepbound, Mounjaro |
| Lexicon Pharmaceuticals, INC. | $145.18 | 2023-2024 | Inpefa |
| Azurity Pharmaceuticals, INC. | $108.37 | 2023-2024 | Edarbi, Edarbyclor, Edarbi |
| Arbor Pharmaceuticals, INC. | $98.26 | 2019-2022 | |
| Corcept Therapeutics | $77.45 | 2025 | Korlym |
| Kestra Medical Technology Services, INC. | $64.78 | 2023-2024 | Assure Wcd |
| Alnylam Pharmaceuticals INC. | $62.73 | 2023-2025 | Onpattro |
| Edwards Lifesciences Corporation | $38.09 | 2019 | |
| Scpharmaceuticals INC. | $30.50 | 2023 | |
| Exact Sciences Corporation | $29.85 | 2023 | Cologuard Collection Kit |
| Baxter Healthcare | $28.14 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Currax Pharmaceuticals LLC | $27.46 | 2020-2021 | |
| Irhythm Technologies, INC. | $23.57 | 2024 | Zio Monitor, Zio Xt Patch |
| Astellas Pharma US INC | $22.88 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $15.59 | 2024 | Arcalyst |
| Bardy Diagnostics, INC. | $15.55 | 2021 | |
| Althera Pharmaceuticals LLC | $15.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandeep Chopra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.